Abatacept and Anti-Tumor Necrosis Factor Monoclonal Antibodies: Efficacy and Safety Comparisons

被引：0
|
作者：
Schiff, M. [1 ]
Dougados, M. [2 ]
Fleischmann, R. [3 ]
Fay, J. [4 ]
Maldonado, M. [4 ]
机构：
[1] Univ Colorado, Denver, CO 80202 USA
[2] Univ Paris 05, Hop Cochin, Paris, France
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2349
引用
收藏
页码：S1004 / S1004
页数：1
相关论文
共 50 条
  • [31] Anti-cyclic citrullinated antibodies and treatment with anti-tumor necrosis factor alpha and rituximab
    Callejas Rubio, Jose Luis
    Roldan, Concepcio Fernandez
    Fernandez, Raquel Rios
    Centeno, Norberto Ortego
    MEDICINA CLINICA, 2007, 129 (20): : 799 - 799
  • [32] Pilot study of the safety and tolerability of a monoclonal anti-tumor necrosis factor alpha antibody in patients with alcoholic hepatitis.
    Menon, KV
    Shah, V
    Sodeman, TC
    Gores, GJ
    Wiesner, RH
    Kamath, PS
    Brandhagen, D
    Sandborn, WJ
    Mangan, TF
    Petterson, T
    Therneau, T
    HEPATOLOGY, 2001, 34 (04) : 697A - 697A
  • [33] Safety and switching evaluation of anti-tumor necrosis factor a agents in rheumatologic patients
    Sanmartin, M. Ucha
    Lorenzo, S. Pellicer
    Martinez Roca, C.
    Castro Nunez, I.
    Alvarez Seoane, J.
    Inaraja Bobo, M. T.
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 256 - 257
  • [34] Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
    Rutgeerts, P
    D'Haens, G
    Targan, S
    Vasiliauskas, E
    Hanauer, SB
    Present, DH
    Mayer, L
    Van Hogezand, RA
    Braakman, T
    DeWoody, KL
    Schaible, TF
    Van Deventer, SJH
    GASTROENTEROLOGY, 1999, 117 (04) : 761 - 769
  • [35] Anti-tumor Necrosis Factor Monoclonal Antibody Therapy for Intestinal Behcet Disease in an Adolescent
    Iwama, Itaru
    Kagimoto, Seiichi
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2011, 53 (06): : 686 - 688
  • [36] Adalimumab - A fully human monoclonal anti-tumor necrosis factor-alpha antibody
    Edwards, LA
    FORMULARY, 2003, 38 (05) : 272 - +
  • [37] Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis.
    Mugnier, B
    Bouvenot, G
    REVUE DE MEDECINE INTERNE, 2000, 21 (10): : 854 - 862
  • [38] Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model
    Zulfikaroglu, Ebru
    Kilic, Sevtap
    Islimye, Mine
    Aydin, Murat
    Zergeroglu, Sema
    Batioglu, Sertac
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (04) : 799 - 804
  • [39] Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons
    Barrier, BF
    Bates, GW
    Leland, MM
    Leach, DA
    Robinson, RD
    Propst, AM
    FERTILITY AND STERILITY, 2004, 81 : 775 - 779
  • [40] Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody)
    Burt, MJ
    Frizelle, FA
    Barbezat, GO
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (04) : 465 - U3
12345